dihexa dihexa oral peptide dihexa injection
Description
Rodent studies have reported upregulation of VEGF receptor 2 (VEGFR2) and associated endothelial cell migration markers following BPC-157 administration
Figure 9: Foot flexion contracture grade in mice treated with Dihexa and G-CSF, in comparison to the control group of mice
Less common side effects may include fatigue, vertigo, and hair loss
The following information is based on dosages cited in preclinical animal studies and should be interpreted solely within that context
For additional research-only dosing patterns discussed in scientific literature, see Wolverine Peptide Stack Dosage: A Comprehensive Guide
